Application 208332
- Type
- ANDA
- Sponsor
- APOTEX
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EZETIMIBE | EZETIMIBE | TABLET;ORAL | 10MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208332-001 | EZETIMIBE | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | AB | 2017-06-12 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A208332-001 | EZETIMIBE | 10MG | TABLET / ORAL | 2017-06-12 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-04-08 23:34 UTC | 2022-04 | A208332-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A208332-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A208332-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A208332-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A208332-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A208332-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A208332-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A208332-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A208332-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A208332-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A208332-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A208332-001 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 5877150f-2807-435e-8e5b-a07dc7dbfd27 | 2024-10-21 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 1afdb764-c5da-4982-beae-9be61bdcbcdc | 2024-10-21 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 63ecbbf1-a6de-493f-9710-812ff45cb4d3 | 2024-09-29 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | Glenmark Pharmaceuticals Inc., USA | ac539a72-77e4-419c-b1d9-42002e9cecf7 | 2024-07-31 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| EZETIMIBE | EZETIMIBE | Camber Pharmaceuticals, Inc. | c07fe2e0-dad4-48b5-8a07-7d57a4035ccd | 2024-07-19 | Warnings, Adverse reactions | EZETIMIBE EZETIMIBE |
| Ezetimibe | EZETIMIBE | Bryant Ranch Prepack | d6b4fd12-9954-42ba-b42a-56f3747c47ff | 2024-07-09 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | ScieGen Pharmaceuticals Inc | 11de499b-ad8a-46a6-9021-c8eba72ae414 | 2024-06-12 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | Macleods Pharmaceuticals Limited | ebe3fa4e-82c4-4a9a-9aec-f64019391f4e | 2024-05-13 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | Orient Pharma Co., Ltd. | b6e77d9b-a553-63e0-e053-2a95a90a18fe | 2024-04-15 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | Bryant Ranch Prepack | 11828685-dc27-42d8-a6ff-f110018207d1 | 2024-04-04 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | Bryant Ranch Prepack | 03609879-bad2-4e75-83fe-1e1a2fd300c3 | 2024-04-03 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | Golden State Medical Supply, Inc. | 4a78aa8d-1fe0-4df0-a15b-2350c15aead1 | 2024-03-25 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| ezetimibe | EZETIMIBE | Quallent Pharmaceuticals Health LLC | 68247ce8-e812-42f2-a3ba-0f6e49acca63 | 2024-03-20 | Warnings, Adverse reactions | ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | Ohm Laboratories Inc. | 5b3842f6-c80a-47b8-8a82-b69e465b05f7 | 2024-03-05 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| ezetimibe | EZETIMIBE | Zydus Pharmaceuticals USA Inc. | f852b12f-e25f-415b-b1e2-58955d609507 | 2024-02-27 | Warnings, Adverse reactions | ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 57d19491-cba1-4720-b69d-481574459201 | 2024-02-22 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | Proficient Rx LP | 8b128e52-5d0d-4536-aa1f-be192d0989ad | 2024-01-01 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 9a04678f-e961-45aa-b3bb-e38e66856edc | 2023-09-21 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | Proficient Rx LP | fbbe54c3-59a1-436c-aba8-188ba7ca70e0 | 2022-08-01 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
| Ezetimibe | EZETIMIBE | Proficient Rx LP | 5cbd9bce-e02d-440f-95d5-4eb958d2f4f3 | 2019-10-01 | Warnings, Adverse reactions | Ezetimibe EZETIMIBE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0904-6664 | Ezetimibe | Ezetimibe | Major Pharmaceuticals | ANDA | Current |
| 0904-6664 | Ezetimibe | Ezetimibe | Major Pharmaceuticals | ANDA | Current |
| 0904-6664 | Ezetimibe | Ezetimibe | Major Pharmaceuticals | ANDA | Current |
| 42291-314 | Ezetimibe | Ezetimibe | AvKARE, Inc. | ANDA | Current |
| 42291-314 | Ezetimibe | Ezetimibe | AvKARE, Inc. | ANDA | Current |
| 50090-3402 | Ezetimibe | Ezetimibe | A-S Medication Solutions | ANDA | Current |
| 60505-2945 | Ezetimibe | Ezetimibe | Apotex Corp. | ANDA | Current |
| 71335-1354 | Ezetimibe | Ezetimibe | Bryant Ranch Prepack | ANDA | Current |